Skip to main content
. 2020 Jun 27;14(10):2375–2383. doi: 10.1002/1878-0261.12746

Fig. 1.

Fig. 1

Association of clinical and pathological features and TERT promoter mutations. N/A, not applicable; THP, pirarubicin.